InsidersTradesSigma
Follow the 리메드 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 리메드 has published 9 public disclosures. Market capitalisation: €82.2bn. The latest transaction was reported on 4 May 2026 (Other). Among the most active insiders: 이근용. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
리메드 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se centra en el desarrollo de soluciones innovadoras para la atención médica.